BrainsWay Balance Sheet Health
Financial Health criteria checks 6/6
BrainsWay has a total shareholder equity of $44.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $72.1M and $28.1M respectively. BrainsWay's EBIT is $1.1M making its interest coverage ratio -1.3. It has cash and short-term investments of $48.1M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -1.3x |
| Cash | US$48.13m |
| Equity | US$44.03m |
| Total liabilities | US$28.07m |
| Total assets | US$72.10m |
Recent financial health updates
No updates
Recent updates
BrainsWay: Cash Flow Doubts Weigh On The Stock
Nov 13BrainsWay: Operating Leverage Driving Upside
Aug 13BrainsWay: An Interesting Niche Concern
Jul 22BrainsWay: Profitable, Growing, And Cheap
Mar 07BrainsWay Q4 Earnings Preview
Feb 27BrainsWay gets significant private insurance coverage from Cigna for OCD treatment Utilizing Deep TMS
Sep 14BrainsWay adds 20% on FDA nod for depression therapy
Aug 29Brainsway GAAP EPS of -$0.07 in-line, revenue of $8.01M misses by $0.41M
Aug 10BrainsWay's Shares Look Attractive
Jul 12BrainsWay's Competitive Advantage Is Growing
Jan 21BrainsWay: Still Undervalued (Still)
Jun 02BrainsWay gets FDA clearance for Deep TMS protocol in major depressive disorder treatment
Apr 26Brainsway: Still Undervalued
Dec 24Brainsway +4% on Q3 beat, bottom-line up 66%
Nov 18Financial Position Analysis
Short Term Liabilities: BWAY's short term assets ($57.3M) exceed its short term liabilities ($12.7M).
Long Term Liabilities: BWAY's short term assets ($57.3M) exceed its long term liabilities ($15.4M).
Debt to Equity History and Analysis
Debt Level: BWAY is debt free.
Reducing Debt: BWAY had no debt 5 years ago.
Debt Coverage: BWAY has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: BWAY has no debt, therefore coverage of interest payments is not a concern.